
David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
David McIntosh, Chair of the UK Plasma Action Alliance (UKPA), reposted from Global Plasma Supply, on an emerging fight on Linkedin:
“The post here below is worth reposting daily, until the WHO, the European Blood Alliance, the International Plasma and Fractionation Association and a host of other misguided organisations drop their antiquated, unethical and utterly counter-productive opposition to Voluntary Reasonably Compensated Donation (VRCD) of human plasma.
Those who foster – and spread – baseless fears about the ‘dangers’ and ‘evils’ of large scale VRCD collection systems are
a) arguing against the system that is the prime global life-saver in the plasma-derived medicines field – currently four times more effective than the unpaid systems;
and
b) they are inhibiting, globally, the development of the increased VRCD systems that are so badly needed to deliver to patients the medicines they need.
The result …. ? …. millions of patients left untreated …. untold suffering … and millions of avoidable deaths.
Why …? … just because some well-meaning but utterly misguided zealots believe, and preach, that VRCD is ‘wrong’.
The hell it is!
It’s a life-saver!
AND, lest there be any doubt about this, everyone needs to be aware that some 80% of patients in the World today who suffer from ailments that can be, and should be, treated by plasma-derived medicines – 80% – are getting little or no such medicine at all. The paid-v-unpaid donation debate is not just a waste of time. It’s a deplorable waste of lives.
Please let’s stop all the nonsense and get on with the job – saving lives through effective plasma collection and supply – globally – via VRCD -VOLUNTARY REASONABLY COMPENSATED DONATION.”
Global Plasma Supply shared on LinkedIn:
”PAID or UNPAID — Lives Are Still Being Lost.
Let’s get one thing straight.
While the world debates how donors give, patients are still waiting. Still suffering. Still dying.
We hear the same tired argument over and over again:
“Paid plasma programs will kill altruism.”
Wrong.
- Proven wrong across Canada, the U.S., Germany, Austria, Hungary, and beyond.
- The data is clear: plasma centers don’t reduce whole blood donations — they increase them.
- 2020 study: for every 100 additional plasma donations, blood banks saw 8–10 extra whole blood units.
- Meta-analyses show no motivational crowd-out effect with incentives.
- EU nations with paid plasma systems have higher blood donation rates than many of those without.
Truth bomb: We’re not running out of altruism.
We’re running out of capacity and boldness.
So why are we still stuck arguing over T-shirts vs stipends?
Global Plasma Supply LTD stands for life.
We believe in both red cell donors and plasma donors.
We believe in choice, in new systems, and in ethical, evidence-based expansion.
We don’t just build plasma centers.
We build bridges between donation types.
We raise awareness in new communities.
We paint the ceiling of healthcare with both colors — red and gold.
Because the goal isn’t how it’s given.
It’s that it’s given — before it’s too late.”
Stay updated on the emerging topics in the field of transfusion medicine with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals